Investec Bank Plc has filed a Form 8.5 regulatory disclosure revealing significant share dealings in Advanced Medical Solutions Group Plc on August 13, 2026.
The disclosure was made under Rule 8.5 of the Takeover Code, which governs public dealing disclosures by exempt principal traders with recognised intermediary status.
Investec Bank Plc is acting in a client-serving capacity in relation to these dealings, as required under the regulatory framework governing takeover activity.
The filing confirms that Investec serves as Advisor and Joint Broker to Advanced Medical Solutions Group Plc, establishing its connected status under the Takeover Code.
During the dealing period, Investec purchased a total of 521,750 ordinary shares in Advanced Medical Solutions Group at prices ranging from 281.5p to 281.75p per unit.
On the sell side, Investec disposed of 660,188 ordinary shares, with prices ranging between 281p and 281.75p per unit during the same session.
The volume of shares sold exceeded purchases during the session, with 660,188 shares sold compared to 521,750 shares bought across the ordinary share class.
No cash-settled derivative transactions, stock-settled derivatives, or options activity was reported as part of this disclosure filing.
Investec confirmed there are no indemnity arrangements, option agreements, or understandings that could serve as an inducement to deal or refrain from dealing with any party to the offer.
The bank also confirmed no agreements or arrangements exist relating to voting rights under any option or derivative referencing Advanced Medical Solutions Group securities.
The disclosure was formally dated August 14, 2026, with contact details provided for Abhishek Gawde, the named contact for the filing.
Rule 8 disclosures of this nature must be submitted to a Regulatory Information Service, with the Panel’s Market Surveillance Unit available for guidance on dealing disclosure obligations.
